This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lorenzo, J. Articles by Choi, Y. Search for Related Content PubMed PubMed Citation Articles by Lorenzo, J. Articles by Choi, Y.

Osteoimmunology: Interactions of the Bone and Immune System

Department of Medicine and the Musculoskeletal Institute (J.L.), The University of Connecticut Health Center, Farmington, Connecticut 06030; Department of Orthopaedics (M.H.), Yale University School of Medicine, New Haven, Connecticut 06510; and Department of Pathology and Laboratory Medicine (Y.C.), The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

Correspondence: Address all correspondence and requests for reprints to: Joseph Lorenzo, M.D., The University of Connecticut Health Center, N4054, MC5456, 263 Farmington Avenue, Farmington, Connecticut 06030-5456. E-mail: jlorenzo{at}nso2.uchc.edu

Bone and the immune system are both complex tissues that respectively regulate the skeleton and the body’s response to invading pathogens. It has now become clear that these organ systems often interact in their function. This is particularly true for the development of immune cells in the bone marrow and for the function of bone cells in health and disease. Because these two disciplines developed independently, investigators in each don’t always fully appreciate the significance that the other system has on the function of the tissue they are studying. This review is meant to provide a broad overview of the many ways that bone and immune cells interact so that a better understanding of the role that each plays in the development and function of the other can develop. It is hoped that an appreciation of the interactions of these two organ systems will lead to better therapeutics for diseases that affect either or both.

This article has been cited by other articles:

				J.-D. Ji, K.-H. Park-Min, Z. Shen, R. J. Fajardo, S. R. Goldring, K. P. McHugh, and L. B. Ivashkiv Inhibition of RANK Expression and Osteoclastogenesis by TLRs and IFN-{gamma} in Human Osteoclast Precursors J. Immunol., December 1, 2009; 183(11): 7223 - 7233. [Abstract] [Full Text] [PDF]

				A. V. Sauer, E. Mrak, R. Jofra Hernandez, E. Zacchi, F. Cavani, M. Casiraghi, E. Grunebaum, C. M. Roifman, M. C. Cervi, A. Ambrosi, et al. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency Blood, October 8, 2009; 114(15): 3216 - 3226. [Abstract] [Full Text] [PDF]

				R Hardy and M S Cooper Bone loss in inflammatory disorders J. Endocrinol., June 1, 2009; 201(3): 309 - 320. [Abstract] [Full Text] [PDF]

				D. Onan, E. H. Allan, J. M. W. Quinn, J. H. Gooi, S. Pompolo, N. A. Sims, M. T. Gillespie, and T. J. Martin The Chemokine Cxcl1 Is a Novel Target Gene of Parathyroid Hormone (PTH)/PTH-Related Protein in Committed Osteoblasts Endocrinology, May 1, 2009; 150(5): 2244 - 2253. [Abstract] [Full Text] [PDF]

				S. Yakar, C. J. Rosen, M. L. Bouxsein, H. Sun, W. Mejia, Y. Kawashima, Y. Wu, K. Emerton, V. Williams, K. Jepsen, et al. Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism FASEB J, March 1, 2009; 23(3): 709 - 719. [Abstract] [Full Text] [PDF]

				Y. Behl, M. Siqueira, J. Ortiz, J. Li, T. Desta, D. Faibish, and D. T. Graves Activation of the Acquired Immune Response Reduces Coupled Bone Formation in Response to a Periodontal Pathogen J. Immunol., December 15, 2008; 181(12): 8711 - 8718. [Abstract] [Full Text] [PDF]

				K. A. Blackwell, C. C. Pilbeam, and L. G. Raisz Take Two Aspirin: for Osteoporosis? IBMS BoneKEy, November 1, 2008; 5(11): 436 - 440. [Full Text] [PDF]